Timing of Surgery And Outcome in Burn Patients ( EARLYBURN ) (EARLYBURN)

Impact of Timing of Surgery on Outcome of Severely Ill Burn Patients

The prognostic of burn patients has improved over the last decades. Early excision of full thickness burns is thought to be one of the key factors which have led to prognostic improvement. Best timing for burn excision remain uncertain, however. In this multicenter observational study, we aim at exploring the impact of timing of surgery on outcome in severely ill burn patients using a propensity analysis.

Study Overview

Detailed Description

The first aim of the study is to explore the impact of timing of the first surgery on outcome of severely ill burn patients. Because a randomization would not be feasible in this setting, we will use a propensity analysis in matching patients receiving early surgery and those receiving late surgery. Secondary aims are to evaluate the impact of the timing of surgery on morbidity (organs failure, infections, sepsis) but also to assess the diagnostic and prognostic value of plasma and urine biomarkers in severely ill burn patients

Study Type

Observational

Enrollment (Actual)

470

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75010
        • Departement of Anesthesiology, Critical Care and Burn Unit; Saint-Louis hospital, University Paris Diderot

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients with extensive skin burns, defined as greater than 20% of the total body surface

Description

Inclusion Criteria:

  • Age >18 years
  • Admission to a burn unit within 72 hours from a burn injury
  • Total burned surface area (TBSA)>20%(2nd degree or 3rd degree) for any type of burn
  • Patient covered by the social security
  • Non-opposition to participate to the study and to the constitution of the biological collection

Exclusion Criteria:

  • Decline to participate
  • Decision not to resuscitate order before surgery
  • Pregnant or breastfeeding patiente
  • Decision to limit therapies in the first 24 hours
  • Patient not resident in France
  • Patient deprived of liberty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Early surgery
Early Excision of full thickness burn First excision surgery of full -thickness burn performed within 48 hours from burn injury
first excision surgery of full -thickness burn performed within 48 hours from burn injury
Other Names:
  • Early
Late surgery
Late Excision of full thickness burn First excision surgery of full -thickness burn performed after 48 hours from burn injury
first excision surgery of full -thickness burn performed after 48 hours from burn injury
Other Names:
  • Late

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
mortality
Time Frame: 90 days
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Median Sequential Organ Failure Assessment score (SOFA score) during first 28 days
Time Frame: First 28 days
Median Sequential Organ Failure Assessment score (SOFA score) during first 28
First 28 days
One year mortality
Time Frame: One year
One year mortality
One year
Organ failure
Time Frame: 28 and 60 days
28 and 60 days
Recovery from acute kidney
Time Frame: Until 28 and 60 days from burn injury
Until 28 and 60 days from burn injury
Nosocomial infections (numbers) during first 60 days
Time Frame: First 60 days
Nosocomial infections (numbers) during first 60 days
First 60 days
Nosocomial sepsis during first 60 days
Time Frame: First 60 days
Nosocomial sepsis during first 60 days
First 60 days
Length of stay in the ICU
Time Frame: One year
Length of stay in the ICU
One year
analog scale of quality of life
Time Frame: One year
Functional sequel at one year, the patient will assesassess his overall quality of life since his accident Scale 1 to 10, with 1: poor, 10: good
One year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthieu Dr Legrand, MD, PhD, Saint-Louis Hospital, Paris, France
  • Principal Investigator: Mourad BENYAMINA, MD, PH, Saint-Louis Hospital, Paris, France

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 25, 2016

Primary Completion (Actual)

December 11, 2023

Study Completion (Actual)

December 11, 2023

Study Registration Dates

First Submitted

October 17, 2016

First Submitted That Met QC Criteria

October 19, 2016

First Posted (Estimated)

October 20, 2016

Study Record Updates

Last Update Posted (Actual)

May 14, 2026

Last Update Submitted That Met QC Criteria

May 11, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Burns

Clinical Trials on Early Excision of full thickness burn

Subscribe